U.S. pharma giant copyright scrapped two experimental weight loss capsules last yr—a after-day by day tablet, lotiglipron, resulting from elevated liver enzymes and a two times-every day pill, danuglipron, on account of potent Unintended effects—but CEO Albert Bourla has claimed the company is determined to “Participate in and earn” inside